Clinical Associates highlights the pervasive risk of Actinic Keratosis (AK), its potential escalation to skin cancer, and stresses the importance of early detection and prevention
(PRUnderground) August 17th, 2023
Clinical Associates, dermatologists near Baltimore, MD, are raising awareness about the prevalence of Actinic Keratosis (AK), a common precancerous skin condition. With over 58 million Americans affected by one or more AKs, the organization emphasizes the critical need for early detection and preventative strategies.
AK, often resulting from prolonged exposure to ultraviolet (UV) radiation, is a significant precursor to squamous cell carcinoma (SCC), the second most common form of skin cancer. While only 5-10% of AKs progress to skin cancer, most SCC cases stem from existing AKs. The dermatologists at Clinical Associates are well-equipped to diagnose and treat this condition alongside a broad range of other dermatological concerns.
“Our dermatologists help patients address and overcome common and rare dermatological conditions, including AK,” said Dr. Sean Gunning, dermatologist at Clinical Associates. “For those suffering from skin conditions like AK, finding appropriate medical treatment can alleviate years of pain or physical discomfort.”
Recognizing the symptoms of AK is crucial for early detection. These could symptoms include; rough, dry, scaly patches or spots on the skin, itching or burning in the affected area, the emergence of a cutaneous horn, which looks like a horn growing out of your skin, the patches or spots can be pink, red, or brown, the skin growths may start as flat, scaly areas and later grow into a tough, wart-like surface, AKs often feel hard, wart-like, or gritty, almost like sandpaper or an animal’s tongue.
If you notice any of these symptoms or any other skin changes that concern you, promptly schedule an appointment with a dermatologist. Remember, your health is paramount; any potential issue deserves professional evaluation and care.
Clinical Associates believes in educating patients on prevention. It’s important to remember that exposure to the sun is a primary cause of Actinic Keratosis. Therefore, protecting your skin from the sun, avoiding the midday sun, wearing protective clothing, using sunscreen year-round, and avoiding tanning beds are all steps individuals can take to prevent this condition.
Regular skin checks for new growths or changes in existing moles, freckles, bumps, and birthmarks can also be crucial for early detection and treatment. By taking these preventative measures, individuals can reduce their risk of developing Actinic Keratosis and other related skin conditions.
As the potential for AK to escalate to skin cancer persists, Clinical Associates urges individuals to schedule regular skin check-ups. Early detection and prevention of AK and other skin conditions can significantly reduce the risk of developing skin cancer. For more information or to schedule a dermatology appointment, contact Clinical please visit https://clinicalassociatesmd.com/specialities/dermatology/
In addition to treating AK and other skin conditions, Clinical Associates also offers cosmetic procedures such as Botox injections, dermal fillers, and microdermabrasion, furthering their commitment to helping patients be at their best at any age. The healthcare provider also offers Puva treatments for eczema and psoriasis issues in their Reisterstown location.
About Clinical Associates
Clinical Associates has been a premier provider of integrated medical care in Maryland for over 50 years, offering a wide range of specialties and comprehensive healthcare services. With a focus on patient-centered care, our team of over 50 physicians, specialists, and credentialed healthcare providers works together to deliver personalized treatment plans and coordinate care across multiple disciplines. Clinical Associates is dedicated to making healthcare more accessible and convenient for patients.
The post Clinical Associates Sheds Light on Actinic Keratosis, the Silent Precursor to Skin Cancer first appeared on
Original Press Release.